International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-4 doi: 10.5281/zenodo.8156433
Original Article
Surgical Management of Anterior Cruciate Ligament Injuries by Arthroscopic Reconstruction Using Semitendinosus and Gracilis Tendon
 ,
 ,
Published
July 15, 2023
Abstract

Background: Anterior cruciate ligament (ACL) and meniscal injuries pose significant challenges for individuals of all age groups. Arthroscopic reconstruction, utilizing hamstring tendon autografts, has emerged as an effective approach for restoring knee function and reducing morbidity. The aim of this study was to assess the functional outcome of combined arthroscopic reconstruction for ACL injuries using semitendinosus and gracilis autografts.

 

Materials and Methods: A total of 20 patients with ACL tears were enrolled in this study. All patients underwent arthroscopic ACL reconstruction using hamstring tendon autografts. The functional outcomes were evaluated using the International Knee Documentation 2000 Score (IKDC) and Lysholm Knee Scoring Scale. Data analysis was conducted using the IBM SPSS software, employing the chi-square test.

 

Results: Our findings demonstrate that arthroscopic anterior cruciate ligament reconstruction using hamstring autografts yields excellent to good functional outcomes in 80% of patients. Through careful patient selection and adherence to a comprehensive physiotherapy protocol, most patients can expect to regain full occupational and recreational activities within four to six months following the procedure.

Recommended Articles
Loading Image...
Volume-4, Issue-4
Citations
1448 Views
304 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved